This company listing is no longer active
IMV Past Earnings Performance
Past criteria checks 0/6
IMV's earnings have been declining at an average annual rate of -26%, while the Biotechs industry saw earnings growing at 32.7% annually. Revenues have been declining at an average rate of 52.1% per year.
Key information
-26.0%
Earnings growth rate
-10.6%
EPS growth rate
| Biotechs Industry Growth | 51.1% |
| Revenue growth rate | -52.1% |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How IMV makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 0 | -38 | 17 | 0 |
| 30 Sep 22 | 0 | -41 | 17 | 0 |
| 30 Jun 22 | 0 | -43 | 18 | 0 |
| 31 Mar 22 | 0 | -40 | 17 | 0 |
| 31 Dec 21 | 0 | -37 | 16 | 0 |
| 30 Sep 21 | 0 | -32 | 15 | 0 |
| 30 Jun 21 | 0 | -28 | 13 | 0 |
| 31 Mar 21 | 0 | -26 | 12 | 0 |
| 31 Dec 20 | 0 | -26 | 11 | 0 |
| 30 Sep 20 | 0 | -25 | 10 | 0 |
| 30 Jun 20 | 0 | -24 | 9 | 0 |
| 31 Mar 20 | 0 | -22 | 8 | 0 |
| 31 Dec 19 | 0 | -21 | 8 | 0 |
| 30 Sep 19 | 0 | -20 | 7 | 0 |
| 30 Jun 19 | 0 | -19 | 7 | 0 |
| 31 Mar 19 | 0 | -19 | 7 | 0 |
| 31 Dec 18 | 0 | -16 | 7 | 0 |
| 30 Sep 18 | 0 | -15 | 7 | 0 |
| 30 Jun 18 | 0 | -12 | 6 | 0 |
| 31 Mar 18 | 0 | -10 | 5 | 0 |
| 31 Dec 17 | 0 | -10 | 5 | 0 |
| 30 Sep 17 | 0 | -9 | 4 | 0 |
| 30 Jun 17 | 0 | -8 | 4 | -1 |
| 31 Mar 17 | 0 | -7 | 3 | -1 |
| 31 Dec 16 | 0 | -7 | 3 | 0 |
| 30 Sep 16 | 0 | -6 | 3 | 1 |
| 30 Jun 16 | 0 | -6 | 3 | 3 |
| 31 Mar 16 | 0 | -7 | 3 | 4 |
| 31 Dec 15 | 0 | -6 | 3 | 3 |
| 30 Sep 15 | 0 | -6 | 3 | 3 |
| 30 Jun 15 | 0 | -6 | 3 | 3 |
| 31 Mar 15 | 0 | -5 | 2 | 3 |
| 31 Dec 14 | 0 | -6 | 3 | 3 |
| 30 Sep 14 | 0 | -5 | 2 | 3 |
| 30 Jun 14 | 0 | -5 | 2 | 3 |
| 31 Mar 14 | 0 | -5 | 3 | 2 |
| 31 Dec 13 | 0 | -4 | 3 | 2 |
| 30 Sep 13 | 0 | -5 | 3 | 3 |
| 30 Jun 13 | 0 | -6 | 3 | 3 |
| 31 Mar 13 | 0 | -6 | 3 | 3 |
| 31 Dec 12 | 0 | -6 | 3 | 3 |
| 30 Sep 12 | 0 | -6 | 3 | 3 |
Quality Earnings: IMV is currently unprofitable.
Growing Profit Margin: IMV is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IMV is unprofitable, and losses have increased over the past 5 years at a rate of 26% per year.
Accelerating Growth: Unable to compare IMV's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IMV is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-11%).
Return on Equity
High ROE: IMV's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.